cognitive processing therapy
BehavioralPsychological treatment for patients suffering from PTSD and SUD symptoms.
NCT Number: NCT03469128
The present research was aimed at comparing the effects of Cognitive Processing Therapy (CPT) with the effects of Sertraline in treating patients who have dual diagnosis PTSD & SUD. The present study examines the extent to which CPT is effective in treating PTSD symptoms for patients with PTSD and SUD.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 1
Patients with co-occurrence PTSD & SUD disorders were grouped into 3 groups: first: Cognitive Processing Therapy (CPT) in which participants completed 12 sessions of CPT. Second: were treated by Sertraline. Third: a placebo control group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Psychological treatment for patients suffering from PTSD and SUD symptoms.
Sertraline for the treatment of post-traumatic stress and SU disorders
Other names: SSRI
Placebo Control
Time frame: 3 Months
A psychological parameter will be measured to check the efficacy of CPT against medication for the treatment for co-current PTSD & SUD. The groups will be examined to show if any significant reductions in PTSD and SUD symptoms was obtained over time.
British University In Egypt
Other
Cognitive Processing Therapy Versus Sertraline for the Treatment of Post-traumatic Stress Disorder & Substance Use Disorder Egyptian Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04763681
COVID-19, Coronaviridae Infections
Toronto, Ontario, Canada
View Trial DetailsNCT04747249
COVID-19, Coronaviridae Infections
Caen, France
View Trial DetailsNCT05662423
Depression, Postpartum, Depressive Disorder
Boston, Massachusetts, United States
View Trial DetailsNCT07737652
Anxiety, Anxiety Disorders
Tuscaloosa, Alabama, United States
View Trial Details